Results 11 to 20 of about 272,695 (294)

Del ocio al neg-ocio... y otra vez al ocio [PDF]

Papers. Revista de Sociologia, 1997
A través de la historia del pensamiento social se analiza el binomio ocio/negocio en términos de actividad y tiempo.Through the history of social thought the dicotomic relationship between leisure and business is analysed in terms of activity and use of ...
Rul·lán Buades, Gaspar
core   +8 more sources

Ocio y turismo

Revista de Estudios Turísticos, 2023
Los turistas dedican gran parte de su tiempo libre en el ocio. Los modos en que utilizan su tiempo libre revelan diferentes actitudes, que el autor distingue en tres grupos: El primero incluye aquellos que buscan entretenimiento y descanso a través de actividades seleccionadas.
Alfredo Sotomayor
semanticscholar   +3 more sources

Small-sized asset owners’ OCIO selections and evaluations [PDF]

Seonmul yeongu, 2023
– This study analyzes small-sized asset owners’ optimal choice problems in selecting an outsourced chief investment officer (OCIO). While large-sized asset owners can select OCIOs through procurement auctions, it is difficult for small-sized asset ...
Deahyeon Park, Doo Jin Ryu
doaj   +2 more sources

OCIO Y TRABAJO EN CLAVE DE BUEN VIVIR. REFLEXIONES PARA CONSTRUIR OTRO FUTURO

Trabalho Necessário
Atrás quedan las promesas del “desarrollo”, nutridas de uno de los corazones de la Modernidad: el “progreso”. En la vorágine, estamos abocados a replantearnos el tema del trabajo y del ocio.
Alberto Acosta
doaj   +2 more sources

European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma. [PDF]

Hemasphere
Abstract Given the evolving understanding of genetic risk factors in multiple myeloma (MM), this paper assesses whether next‐generation sequencing (NGS) could complement or even replace fluorescence in situ hybridization (FISH) at diagnosis. A structured consensus process within European Myeloma Network (EMN) clinical and laboratory groups was ...
Bolli N, D'Agostino M, Bagratuni T, Boccadoro M, Cavo M, Driessen C, Einsele H, Engelhardt M, Gay F, Gutiérrez NC, Hájek R, Holien T, João C, Kaiser M, Kortüm KM, Leypoldt L, Moreau P, Musto P, Ocio EM, Raab MS, Rasche L, Schjesvold F, Sevcikova T, Terpos E, Touzeau C, Van de Donk NWCJ, van Duin M, Weisel K, Zamagni E, Cupedo T, Sonneveld P, Terragna C.   +31 more
europepmc   +2 more sources

European Expert Panel Consensus on Outpatient Administration of Teclistamab and Talquetamab in Patients With Multiple Myeloma: Feasibility, Key Considerations, and Future Directions. [PDF]

Eur J Haematol
ABSTRACT Objectives Teclistamab and talquetamab treatments are typically initiated in a hospital due to the potential risk of cytokine release syndrome. However, emerging data support the potential for outpatient administration (i.e., administration without overnight hospital admission).
Lund T, Khandanpour C, Anguille S, Kisro J, Krauth MT, Lund J, Nijhof I, Ocio EM, Zamagni E, Javelot M, Albrecht C, Cerezo CE, Perrot A.   +12 more
europepmc   +2 more sources

High-risk features of early relapse in newly-diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapy. [PDF]

Hemasphere
Abstract Patients with newly‐diagnosed multiple myeloma (MM) who experience early relapse (ER) have dismal overall survival (OS). Their prospective identification, either before or soon after treatment initiation, is paramount to use alternative approaches and prevent ER.
Manubens A, Paiva B, Gutiérrez NC, Fernandez M, Calasanz MJ, Rosiñol L, Oriol A, Blanchard MJ, Carrillo E, Benavente C, Martínez-López J, Bargay J, Hernández MT, de la Rubia J, González Y, Paricio M, de Arriba F, Ocio EM, Teruel AI, de la Guia AL, Sirvent M, Gironella M, Sampol A, Arguiñano JM, Cabrera C, Alegre A, Granell M, Cabañas V, Núñez-Córdoba JM, Mateos MV, Lahuerta JJ, San Miguel JF, Bladé J, Rodriguez-Otero P.   +33 more
europepmc   +2 more sources

DRUGGABLE MM THERAPEUTICS: PATHOGENETIC PATHWAYS [PDF]

HemaSphere, 2022
Enrique M Ocio
doaj   +2 more sources

Ocio y prospección

Revista Española de Pedagogía, 2023
Agustín Escolano
openalex   +2 more sources

30-Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis. [PDF]

Hemasphere
HemaSphere, Volume 8, Issue 11, November 2024.
Ocio EM, Perrot A, Moreau P, Mateos MV, Bringhen S, Martínez-López J, Karlin L, Wang SY, Oprea C, Li Y, Kodas E, San-Miguel J.   +11 more
europepmc   +2 more sources